Global Prostate Cancer Testing Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 2046

Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
There are many new drugs that have increased the life expectancy of prostate cancer patients and have been approved by the Food & Drug Administration. But these drugs are having a high cost, which is a threat for the patients and the insurers, both. These expensive drugs are not being paid by the insurance companies and the reimbursement level for them is very low. Hence, only few people are capable of affording these drugs. Therefore, because of this high cost, the use of generic drugs is more, and hence, it is hindering the growth of the prostate cancer drugs market.
North America is the leading global market with the largest revenue share in 2017. Due to the rising prevalence of the diseases and high mortality rate of the prostate cancer in the United States, North America is dominating the market. Asia-Pacific is also projected to be the fastest growing region due to the improving healthcare infrastructure and the growing investments by the key market players.
In 2018, the global Prostate Cancer Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Prostate Cancer Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Testing development in United States, Europe and China.

The key players covered in this study
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Market segment by Type, the product can be split into
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others

Market segment by Application, split into
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prostate Cancer Testing status, future forecast, growth opportunity, key market and key players.
To present the Prostate Cancer Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Prostate Cancer Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prostate Cancer Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 PSA Tests
1.4.3 CTC Tests
1.4.4 Immunohistochemistry
1.4.5 PCA3 Tests
1.4.6 Others
1.5 Market by Application
1.5.1 Global Prostate Cancer Testing Market Share by Application (2014-2025)
1.5.2 Hospital Associated Labs
1.5.3 Independent Diagnostic Laboratories
1.5.4 Cancer Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Prostate Cancer Testing Market Size
2.2 Prostate Cancer Testing Growth Trends by Regions
2.2.1 Prostate Cancer Testing Market Size by Regions (2014-2025)
2.2.2 Prostate Cancer Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Prostate Cancer Testing Market Size by Manufacturers
3.1.1 Global Prostate Cancer Testing Revenue by Manufacturers (2014-2019)
3.1.2 Global Prostate Cancer Testing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Prostate Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.2 Prostate Cancer Testing Key Players Head office and Area Served
3.3 Key Players Prostate Cancer Testing Product/Solution/Service
3.4 Date of Enter into Prostate Cancer Testing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Prostate Cancer Testing Market Size by Type (2014-2019)
4.2 Global Prostate Cancer Testing Market Size by Application (2014-2019)

5 United States
5.1 United States Prostate Cancer Testing Market Size (2014-2019)
5.2 Prostate Cancer Testing Key Players in United States
5.3 United States Prostate Cancer Testing Market Size by Type
5.4 United States Prostate Cancer Testing Market Size by Application

6 Europe
6.1 Europe Prostate Cancer Testing Market Size (2014-2019)
6.2 Prostate Cancer Testing Key Players in Europe
6.3 Europe Prostate Cancer Testing Market Size by Type
6.4 Europe Prostate Cancer Testing Market Size by Application

7 China
7.1 China Prostate Cancer Testing Market Size (2014-2019)
7.2 Prostate Cancer Testing Key Players in China
7.3 China Prostate Cancer Testing Market Size by Type
7.4 China Prostate Cancer Testing Market Size by Application

8 Japan
8.1 Japan Prostate Cancer Testing Market Size (2014-2019)
8.2 Prostate Cancer Testing Key Players in Japan
8.3 Japan Prostate Cancer Testing Market Size by Type
8.4 Japan Prostate Cancer Testing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Prostate Cancer Testing Market Size (2014-2019)
9.2 Prostate Cancer Testing Key Players in Southeast Asia
9.3 Southeast Asia Prostate Cancer Testing Market Size by Type
9.4 Southeast Asia Prostate Cancer Testing Market Size by Application

10 India
10.1 India Prostate Cancer Testing Market Size (2014-2019)
10.2 Prostate Cancer Testing Key Players in India
10.3 India Prostate Cancer Testing Market Size by Type
10.4 India Prostate Cancer Testing Market Size by Application

11 Central & South America
11.1 Central & South America Prostate Cancer Testing Market Size (2014-2019)
11.2 Prostate Cancer Testing Key Players in Central & South America
11.3 Central & South America Prostate Cancer Testing Market Size by Type
11.4 Central & South America Prostate Cancer Testing Market Size by Application

12 International Players Profiles
12.1 Genomic Health
12.1.1 Genomic Health Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prostate Cancer Testing Introduction
12.1.4 Genomic Health Revenue in Prostate Cancer Testing Business (2014-2019)
12.1.5 Genomic Health Recent Development
12.2 OPKO
12.2.1 OPKO Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prostate Cancer Testing Introduction
12.2.4 OPKO Revenue in Prostate Cancer Testing Business (2014-2019)
12.2.5 OPKO Recent Development
12.3 Siemens Healthcare
12.3.1 Siemens Healthcare Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prostate Cancer Testing Introduction
12.3.4 Siemens Healthcare Revenue in Prostate Cancer Testing Business (2014-2019)
12.3.5 Siemens Healthcare Recent Development
12.4 DiaSorin
12.4.1 DiaSorin Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prostate Cancer Testing Introduction
12.4.4 DiaSorin Revenue in Prostate Cancer Testing Business (2014-2019)
12.4.5 DiaSorin Recent Development
12.5 bioMeriux
12.5.1 bioMeriux Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prostate Cancer Testing Introduction
12.5.4 bioMeriux Revenue in Prostate Cancer Testing Business (2014-2019)
12.5.5 bioMeriux Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prostate Cancer Testing Introduction
12.6.4 Roche Revenue in Prostate Cancer Testing Business (2014-2019)
12.6.5 Roche Recent Development
12.7 MDx Health
12.7.1 MDx Health Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prostate Cancer Testing Introduction
12.7.4 MDx Health Revenue in Prostate Cancer Testing Business (2014-2019)
12.7.5 MDx Health Recent Development
12.8 Beckman Coulter
12.8.1 Beckman Coulter Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prostate Cancer Testing Introduction
12.8.4 Beckman Coulter Revenue in Prostate Cancer Testing Business (2014-2019)
12.8.5 Beckman Coulter Recent Development
12.9 Myriad Genetics
12.9.1 Myriad Genetics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prostate Cancer Testing Introduction
12.9.4 Myriad Genetics Revenue in Prostate Cancer Testing Business (2014-2019)
12.9.5 Myriad Genetics Recent Development
12.10 Ambry Genetics
12.10.1 Ambry Genetics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prostate Cancer Testing Introduction
12.10.4 Ambry Genetics Revenue in Prostate Cancer Testing Business (2014-2019)
12.10.5 Ambry Genetics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details